Resveratrol as a Preventive Treatment of OHSS

• Status: Completed
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Evaluation of resveratrol treatment oh ovarian hyperstimulation syndrome in egg donors

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: IVI Madrid
• Treatments: Resveratrol

Criteria

Inclusion Criteria:

• Number of follicles greater than 12 mm after ovarian stimulation

• Number of retrieved oocytes greater than 21

Exclusion Criteria:

• >35 years-old

• PCOS

• Endometriosis

• Systemic pathology

• Positive serologies for HBV, HBC and HIV

• Abnormal karyotype